Advertisement

Autoantibodies pp 177-182 | Cite as

Analysis of C3 Nephritic Factors by ELISA

  • Lillemor Skattum
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1901)

Abstract

Autoantibodies to the C3 convertase of the alternative pathway of complement, called C3 nephritic factors (C3NeF), cause persistently low C3 in the circulation and production of C3 degradation fragments due to prolonged stabilization of the C3 convertase. C3NeF are associated with glomerulopathy, acquired partial lipodystrophy, and less frequently with increased susceptibility to meningococcal infection. Analysis of C3NeF is an important part of the diagnostic workup of C3 glomerulopathy, but their identification is difficult presumably due to considerable heterogeneity. Therefore it is recommended to use a combination of different analysis methods for the detection of C3NeF. Here we present an ELISA method for detection of C3NeF.

Key words

Autoantibodies to complement C3 nephritic factors ELISA C3 glomerulopathy Alternative pathway convertase 

References

  1. 1.
    Riedl M, Thorner P, Licht C (2017) C3 Glomerulopathy. Pediatr Nephrol 32(1):43–57CrossRefGoogle Scholar
  2. 2.
    Egan M, Sullivan K, Frazer-Abel A, Cunningham-Rundles C (2016) A healthy female with C3 hypocomplementemia and C3 nephritic factor. Clin Immunol 169:14–15CrossRefGoogle Scholar
  3. 3.
    Karstorp A (1976) C3 activator and hypocomplementaemia in a "healthy" woman. Br Med J 1(6008):501–502CrossRefGoogle Scholar
  4. 4.
    Daha MR, Fearon DT, Austen KF (1976) C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol 116(1):1–7PubMedGoogle Scholar
  5. 5.
    Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83(1):18–34CrossRefGoogle Scholar
  6. 6.
    Teisner B, Elling P, Svehag SE et al (1984) C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C 92(6):341–349PubMedGoogle Scholar
  7. 7.
    Daha MR, Van Es LA (1981) Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. Immunology 43(1):33–38PubMedPubMedCentralGoogle Scholar
  8. 8.
    Paixão-Cavalcante D, López-Trascasa M, Skattum L et al (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82(10):1084–1092CrossRefGoogle Scholar
  9. 9.
    Scott DM, Amos N, Sissons JG et al (1978) The immunoglobulin nature of nephritic factor (NeF). Clin Exp Immunol 32(1):12–24PubMedPubMedCentralGoogle Scholar
  10. 10.
    Rother U (1982) A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes. J Immunol Methods 51(1):101–107CrossRefGoogle Scholar
  11. 11.
    Peters DK, Martin A, Weinstein A et al (1972) Complement studies in membranoproliferative glomerulonephritis. Clin Exp Immunol 11:311–320PubMedPubMedCentralGoogle Scholar
  12. 12.
    Williams DG, Peters DK, Fallows J et al (1974) Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol 18(3):391–405PubMedPubMedCentralGoogle Scholar
  13. 13.
    Seino J, vd Wall Bake WL, van Es LA, Daha MR (1993) A novel ELISA assay for the detection of C3 nephritic factor. J Immunol Methods 159(1–2):221–227CrossRefGoogle Scholar
  14. 14.
    Tanuma Y, Ohi H, Hatano M (1990) Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF. Clin Immunol Immunopathol 56(2):226–238CrossRefGoogle Scholar
  15. 15.
    Mollnes TE, Ng YC, Peters DK, Lea T et al (1986) Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. Clin Exp Immunol 65(1):73–79PubMedPubMedCentralGoogle Scholar
  16. 16.
    Marinozzi MC, Chauvet S, Le Quintrec M et al (2017) C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney Int. pii: S0085-2538(17)30309-5Google Scholar
  17. 17.
    Skattum L, Mårtensson U, Sjöholm AG (1997) Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies. J Intern Med 242(6):455–464CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Laboratory Medicine, Section of Microbiology, Immunology and GlycobiologyLund UniversityLundSweden
  2. 2.Clinical Immunology and Transfusion MedicineRegion SkåneSweden

Personalised recommendations